Busulfan in intravenous formulation in hematopoietic stem cell transplantation in paediatric age

被引：0
|
作者：
Prete, A. [1 ]
Rondelli, R. [1 ]
Luksch, R. [1 ]
Fagioli, F. [1 ]
Ripaldi, M. [1 ]
Favre, C. [1 ]
Di Bartolomeo, E. [1 ]
Lanino, E. [1 ]
Ziino, O. [1 ]
Messina, C. [1 ]
Rovelli, A. [1 ]
Caselli, D. [1 ]
Pession, A. [1 ]
Locatelli, F. [1 ]
机构：
[1] CSD Trapianto Cellule Staminali Emopoiet & Terapi, Bologna, Italy
来源：
HEMATOLOGY REPORTS | 2010年 / 2卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Clinical comparison of weight- and age-based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation
    Gokcebay, D. Gurlek
    Azik, F.
    Ozbek, N.
    Isik, P.
    Avci, Z.
    Tavil, B.
    Kara, A.
    Tunc, B.
    PEDIATRIC TRANSPLANTATION, 2015, 19 (03) : 307 - 315
  • [32] Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study
    Jansing, Thaksin
    Sanpakit, Kleebsabai
    Tharnpanich, Trai
    Jiranantakan, Thanjira
    Niphandwongkorn, Vachira
    Chindavijak, Busba
    Suansanae, Thanarat
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (04) : 346 - 357
  • [33] Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation
    Schechter, Tal
    Finkelstein, Yaron
    Doyle, John
    Verjee, Zulfikarali
    Moretti, Myla
    Koren, Gideon
    Dupuis, L. Lee
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (03) : 307 - 314
  • [34] Model-Informed Precision Dosing of Intravenous Busulfan in Thai Pediatrics Undergoing Hematopoietic Stem Cell Transplantation
    Puangpetch, Apichaya
    Thomas, Fabienne
    Anurathapan, Usanarat
    Pakakasama, Samart
    Hongeng, Suradej
    Rachanakul, Jiratha
    Prommas, Santirhat
    Nuntharadthanaphong, Nutthan
    Chatelut, Etienne
    Sukasem, Chonlaphat
    Le Louedec, Felicien
    THERAPEUTIC DRUG MONITORING, 2024, 46 (06) : 778 - 785
  • [35] Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity
    Shimoni, A
    Bielorai, B
    Toren, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Ben-Bassat, I
    Nagler, A
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (05) : 428 - 434
  • [36] Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation
    Cho, Sang-Heon
    Lee, Jung-Hee
    Lim, Hyeong-Seok
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Choe, Sangmin
    Bae, Kyun-Seop
    Lee, Je-Hwan
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2016, 20 (03): : 245 - 251
  • [37] Comparison of Intravenous and Oral Busulfan in Allogeneic Hematopoietic Stem Cells Transplantation in Acute Leukemias
    Valencia Carlo, V. A.
    Valero Saldana, L. M.
    Alfaro, M. A.
    Acosta Maldonado, B. L.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S444 - S444
  • [38] Personalizing busulfan therapy for children undergoing hematopoietic stem cell transplantation
    Tyagi, Anuj K.
    Huezo-Diaz, Patricia
    Ansari, Marc
    PERSONALIZED MEDICINE, 2014, 11 (05) : 463 - 466
  • [39] Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning
    Germeraad, R. S.
    Demandt, A. M. P.
    Rouhl, R. P. W.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [40] Allogeneic hematopoietic stem cell transplantation using IV Busulfan.
    Arat, M
    Beksac, M
    Gurman, G
    Ozcan, M
    Arslan, O
    Soydan, E
    Yazman, D
    Topcuoglu, P
    Ilhan, O
    Koc, H
    Uysal, A
    Konuk, N
    Akan, H
    BLOOD, 2001, 98 (11) : 342B - 342B
12345